NIH-funded research Career grant

Investigating how selective recycling of cellular materials affects aging and neurodegeneration

Official title: Role of selective autophagy in aging and neurodegeneration: a small molecule approach

Funded at Scripps Research Institute, the · NIH-10775823 · Data updated 2026-11-12

This study is looking at how a natural recycling process in our cells, which helps get rid of damaged materials, changes as we age and how it relates to diseases like Alzheimer's, with the hope of finding new ways to keep our brains healthy and possibly slow down memory loss.

More Aging research and trials

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionScripps Research Institute, the
NIH-funded
Lab location1 site (La Jolla, United States)
Project startFebruary 15, 2023
Project endJanuary 31, 2026
Funding year2024
Award (this year)$126,250
NIH project number5K99AG080109-02
Project IDNIH-10775823 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals diagnosed with Alzheimer's disease or those experiencing age-related cognitive decline.

Less likely to help

Patients with neurodegenerative conditions unrelated to Alzheimer's or those in very early stages of cognitive impairment may not benefit from this research.

What this research studies

This research explores the role of selective autophagy, a process that helps cells recycle damaged materials, in the context of aging and neurodegenerative diseases like Alzheimer's. By understanding how this recycling process can be disrupted with age, the researchers aim to identify potential interventions that could improve cellular health and function. The study will involve examining the accumulation of toxic substances in the brain and testing small molecules that may enhance the selective degradation of these harmful materials. Patients may benefit from new therapeutic strategies that target these mechanisms to slow down or prevent neurodegeneration.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that slow the progression of Alzheimer's disease and improve the quality of life for patients.

How similar studies have gone: Previous studies have shown promising results in targeting autophagy for neurodegenerative diseases, indicating that this approach may be effective.

Where this research is happening

  • Scripps Research Institute, the
    La Jolla, United States
    Active

Researchers

  • Principal investigator: Tan, Ee Phie — Scripps Research Institute, the
  • Study coordinator: Tan, Ee Phie

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.